UK referendum on Europe: what’s the potential medtech regulatory fallout?
This article was originally published in Clinica
Executive Summary
For the last two and a half decades, the careers of EU medtech regulatory experts have orbited around the output of Brussels and its impact at EU, national and even international level. So should those of us in the UK fear the referendum on EU membership, as promised by the newly elected Conservative government? How worried should the UK be – and indeed the rest of Europe – in terms of regulatory stability should the outcome of the vote, expected in 2017, signal an exit from the EU? And what will the impact be on the rest of Europe?
You may also be interested in...
EU Regulatory Roundup, March 2024: Busy Agenda In Broad Range Of Key Areas
March was an important month for EU medtech regulation with an interesting spread of news relating to the Medical Device and IVD Regulations, the Batteries Regulation, the Artificial Intelligence Act and more.
EU’s Revised Phthalates Guideline Features New Annexes Focused On Alternatives
The effects of phthalates, plasticizers used in many medical devices, on the human endocrine system, have long been debated. But how safe are the alternatives? Updated guidelines give more insight.
Non-Medical Brain Stimulation Devices: Could They Be Down-Classified Again In the EU?
Six types of products that do not have an intended medical purpose fall under the scope of the Medical Device Regulation. Understanding their risks is complex and subject to regular re-examination by the European Commission.